Acute and late complications after radiotherapy for prostate cancer: Results of a multicenter randomized trial comparing 68 Gy to 78 Gy

This publication has 48 references indexed in Scilit:

• Phase III Trial of Long-Term Adjuvant Androgen Deprivation After Neoadjuvant Hormonal Cytoreduction and Radiotherapy in Locally Advanced Carcinoma of the Prostate: The Radiation Therapy Oncology Group Protocol 92–02
  Journal of Clinical Oncology, 2003
• Conformal High Dose Rate Brachytherapy Improves Biochemical Control And Cause Specific Survival in Patients With Prostate Cancer And Poor Prognostic Factors
  Journal of Urology, 2003
• Dose response in prostate cancer with 8–12 years’ follow-up
  International Journal of Radiation Oncology*Biology*Physics, 2002
• LATE NORMAL TISSUE SEQUELAE IN THE SECOND DECADE AFTER HIGH DOSE RADIATION THERAPY WITH COMBINED PHOTONS AND CONFORMAL PROTONS FOR LOCALLY ADVANCED PROSTATE CANCER
  Journal of Urology, 2002
• HIGH DOSE RADIATION DELIVERED BY INTENSITY MODULATED CONFORMAL RADIOTHERAPY IMPROVES THE OUTCOME OF LOCALIZED PROSTATE CANCER
  Journal of Urology, 2001
• AN ANALYSIS OF WATCHFUL WAITING FOR CLINICALLY LOCALIZED PROSTATE CANCER
  Journal of Urology, 1998
• Neoadjuvant androgen ablation prior to radiotherapy for prostate cancer: Reducing the potential morbidity of therapy
  Urology, 1997
• High-precision prostate cancer irradiation by clinical application of an offline patient setup verification procedure, using portal imaging
  International Journal of Radiation Oncology*Biology*Physics, 1996
• Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European organization for research and treatment of cancer (EORTC)
  International Journal of Radiation Oncology*Biology*Physics, 1995
• The effect of dose on local control of prostate cancer
  International Journal of Radiation Oncology*Biology*Physics, 1988